Analyst · Lisata Therapeutics, Inc. (LSTA) | Ratings, Price Targets & Consensus

Analyst Consensus

Hold2 analysts

Hold

Updated Aug 25, 2026

Total Analysts2

Hold

2

Ratings

Updated Aug 25, 2026

Overall Rating

C

DCF Score4.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$1.55

DCF Value+23.57%

$1.92

Potential upside vs current price

Current Stock Price

$1.55

DCF Value+23.57%

$1.92

Potential upside vs current price

Analyst Consensus

Hold2 analysts

Hold

Updated Aug 25, 2026

Total Analysts2

Hold

2

Ratings

Updated Aug 25, 2026

Overall Rating

C

DCF Score4.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$1.55

DCF Value+23.57%

$1.92

Potential upside vs current price

Current Stock Price

$1.55

DCF Value+23.57%

$1.92

Potential upside vs current price